Advertisement
CAH vs FOCL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Buy and FOCL is a Buy.
CAH in upward trend: 10-day moving average broke above 50-day moving average on October 13, 2026
The 10-day moving average for CAH crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
CAH moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in 264 of 396 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 188 of 310 cases where CAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
Bearish Trend Analysis
The 10-day RSI Indicator for CAH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 26 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CAH as a result. In 39 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for CAH turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 26 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
CAH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-20.167) is normal, around the industry mean (12.781). CAH has a moderately high P/E Ratio (34.538) as compared to the industry average of (10.435). Projected Growth (PEG Ratio) (1.105) is also within normal values, averaging (2.016). Dividend Yield (0.008) settles around the average of (0.139) among similar stocks. P/S Ratio (0.217) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
FOCL in +1.93% Uptrend, advancing for three consecutive days on October 26, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FOCL advanced for three days, in 185 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 56 cases where FOCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on FOCL as a result. In 67 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for FOCL just turned positive on October 21, 2026. Looking at past instances where FOCL's MACD turned positive, the stock continued to rise in 31 of 41 cases over the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
FOCL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for FOCL moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for FOCL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FOCL's P/B Ratio (-61.199) is slightly lower than the industry average of (12.781). P/E Ratio (-4.019) is within average values for comparable stocks, (10.435). FOCL's Projected Growth (PEG Ratio) (8.100) is very high in comparison to the industry average of (2.016). Dividend Yield (0.000) settles around the average of (0.139) among similar stocks. P/S Ratio (1.919) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
CAH | FOCL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 28 Undervalued | 52 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 100 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 12 | 42 | |
P/E GROWTH RATING 1..100 | 14 | 19 | |
SEASONALITY SCORE 1..100 | 23 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CAH's Valuation (28) in the Medical Distributors industry is in the same range as FOCL (52) in the Biotechnology industry. This means that CAH’s stock grew similarly to FOCL’s over the last 12 months.
CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is significantly better than the same rating for FOCL (100) in the Biotechnology industry. This means that CAH’s stock grew significantly faster than FOCL’s over the last 12 months.
CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as FOCL (100) in the Biotechnology industry. This means that CAH’s stock grew similarly to FOCL’s over the last 12 months.
CAH's Price Growth Rating (12) in the Medical Distributors industry is in the same range as FOCL (42) in the Biotechnology industry. This means that CAH’s stock grew similarly to FOCL’s over the last 12 months.
CAH's P/E Growth Rating (14) in the Medical Distributors industry is in the same range as FOCL (19) in the Biotechnology industry. This means that CAH’s stock grew similarly to FOCL’s over the last 12 months.
| CAH | FOCL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 62% | N/A |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 44% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 43% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 65% | 2 days ago 85% |
| Advances ODDS (%) | 15 days ago 67% | 5 days ago 76% |
| Declines ODDS (%) | 3 days ago 43% | 12 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 50% | N/A |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CAH’s FA Score shows that 4 FA rating(s) are green while FOCL’s FA Score has 1 green FA rating(s).
- CAH’s FA Score: 4 green, 1 red.
- FOCL’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CAH’s TA Score shows that 5 TA indicator(s) are bullish while FOCL’s TA Score has 4 bullish TA indicator(s).
- CAH’s TA Score: 5 bullish, 5 bearish.
- FOCL’s TA Score: 4 bullish, 4 bearish.
Price Growth
CAH (@Medical Distributors) experienced а +0.36% price change this week, while FOCL (@Medical Distributors) price change was +0.24% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.68%. For the same industry, the average monthly price growth was -7.47%, and the average quarterly price growth was -23.70%.
Reported Earning Dates
CAH is expected to report earnings on Nov 05, 2026.
FOCL is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Medical Distributors (+1.68% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
CAH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.
| Ticker / NAME | Correlation To CAH | 1D Price Change % | ||
|---|---|---|---|---|
| CAH | 100% | -0.24% | ||
| MCK - CAH | 66% Loosely correlated | +1.40% | ||
| COR - CAH | 58% Loosely correlated | +0.09% | ||
| HSIC - CAH | 11% Poorly correlated | -1.80% | ||
| FOCL - CAH | 5% Poorly correlated | +0.24% | ||
| AHG - CAH | 5% Poorly correlated | -1.56% | ||
More | ||||
FOCL and
Correlation & Price change
A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.
| Ticker / NAME | Correlation To FOCL | 1D Price Change % | ||
|---|---|---|---|---|
| FOCL | 100% | +0.24% | ||
| AORT - FOCL | 29% Poorly correlated | -3.67% | ||
| UFPT - FOCL | 20% Poorly correlated | -3.00% | ||
| SENS - FOCL | 20% Poorly correlated | -2.46% | ||
| STXS - FOCL | 16% Poorly correlated | -5.21% | ||
| HBIO - FOCL | 11% Poorly correlated | +1.14% | ||
More | ||||